Howard Capital Management Group’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
|
|||||
|
2025
Q2 | $219K | Sell |
|
|||||
|
2025
Q1 | $284K | Sell |
|
|||||
|
2024
Q4 | $22.9M | Buy |
|
|||||
|
2024
Q3 | $24.5M | Buy |
|
|||||
|
2024
Q2 | $22.4M | Buy |
|
|||||
|
2024
Q1 | $21.8M | Buy |
|
|||||
|
2023
Q4 | $20M | Buy |
|
|||||
|
2023
Q3 | $15.8M | Buy |
|
|||||
|
2023
Q2 | $17.4M | Buy |
|
|||||
|
2023
Q1 | $15.6M | Sell |
|
|||||
|
2022
Q4 | $17.1M | Buy |
|
|||||
|
2022
Q3 | $16.2M | Sell |
|
|||||
|
2022
Q2 | $15.2M | Buy |
|
|||||
|
2022
Q1 | $17.9M | Buy |
|
|||||
|
2021
Q4 | $21.6M | Buy |
|
|||||
|
2021
Q3 | $23.3M | Buy |
|
|||||
|
2021
Q2 | $24.1M | Buy |
|
|||||
|
2021
Q1 | $23.3M | Buy |
|